UNSPSC 51162501: Acetaminophen/dextromethorphan

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE302. This VA Drug Class (RE302) classifies this compound as belonging to the group NON-OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162501 Acetaminophen/dextromethorphan is a Commodity code that covers pharmaceutical products, though the recent state and local solicitations tagged under it actually seek naloxone, safe drug deactivation systems, and broader generic multi-source pharmaceuticals and over-the-counter products rather than acetaminophen or dextromethorphan specifically. State and local governments use this code family to procure medications and pharmaceutical supplies for community health initiatives, emergency response programs, and government facility distribution networks. Issuing bodies include county health departments and multistate cooperative purchasing alliances that aggregate demand across participating state and local jurisdictions.

Recent activity spans Florida and Minnesota. Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2026) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building; vendors must include shipping and delivery costs, maintain specified insurance, and comply with E-Verify and drug-free workplace requirements, with a potential FEMA funding component. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities, including Oregon; vendors must supply through three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson), demonstrate cGMP and DSCSA compliance, maintain relationships with at least two wholesalers with chargeback systems, and accept a 3 percent administrative fee, with evaluation weighted 75 percent on price competitiveness and 10 percent on fixed pricing for the contract term.